FDA Commissioner Marty Makary Resigns
Digest more
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of President Donald Trump.
Experts weigh in on quitting by text and workplace etiquette after Trump shares alleged FDA resignation message.
By Christy Santhosh May 13 (Reuters) - U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure comes as a positive move after a period of turmoil in the biotech sector, but until a permanent replacement is found,
The resignation of President Donald Trump’s Food and Drug Administration commissioner Tuesday ruffled some feathers in Washington.
Axios on MSN
Makary's exit creates new uncertainty at FDA
Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy. But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure.
Food and Drug Administration Commissioner Marty Makary is set to leave his post on Tuesday, making him the latest in the line of Trump health officials to be ousted this term. Makary, previously a Johns Hopkins University professor of surgery,
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of President Donald Trump.
The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.